Supriya Lifescience Shares Surge Over 16 After Strong Q4FY26 Results PAT Up 47 Revenue Jumps 50 FLEX Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower EU Countries Endorse EUUS Agreement Final Adoption Moves Closer